Patent details

301110 Product Name: Combinatie van afoxolaner, eprinomectine en praziquantel

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301110
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3172964
Status:
Withdrawn
Application number:
301110
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/2/20/267
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/01/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
21/06/2021
First Marketing Authorization date:
07/01/2021
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
21/06/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
27/11/2025
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
21/06/2021
 
 

 

Name:
Boehringer Ingelheim Animal Health USA Inc.
Address:
3239 Satellite Boulevard, Bldg. 500, Duluth, GA 30096, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
21/06/2021
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
49/25
Publication date:
03/12/2025
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
25/21
Publication date:
23/06/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
27/11/2025 Incoming Correspondence Electronic Withdrawal application 1 PDF /4/8/2/5/9/0800695284/docs/301110_12_incomingcorrespondenceelectronic20251127124303911.pdf
27/11/2025 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /4/8/2/5/9/0800695284/docs/301110_13_301110684399l193.pdf
18/11/2025 SPC Documents Annex SPC 53 PDF /4/8/2/5/9/0800695284/docs/301110_9_supplprotectioncertificate20251119015509907.pdf
18/11/2025 Incoming Correspondence Electronic Accompanying letter incoming document 7 PDF /4/8/2/5/9/0800695284/docs/301110_10_incomingcorrespondenceelectronic20251119015439563.pdf
18/11/2025 SPC Documents Annex SPC 65 PDF /4/8/2/5/9/0800695284/docs/301110_11_supplprotectioncertificate20251119015537293.pdf
14/08/2025 Outgoing Correspondence Letter to applicant 4 PDF /4/8/2/5/9/0800695284/docs/301110_8_301110669619l173.pdf
01/11/2021 Incoming Correspondence Paper Incoming Correspondence Paper 5 PDF /4/8/2/5/9/0800695284/docs/301110_4_incomingcorrespondencepaper20211101025439061.pdf
02/08/2021 Outgoing Correspondence Letter to applicant 2 PDF /4/8/2/5/9/0800695284/docs/301110_5_420824l173.pdf
21/06/2021 SPC Documents Annex SPC 1 PDF /4/8/2/5/9/0800695284/docs/301110_0_supplprotectioncertificate20210621123339761.pdf
21/06/2021 SPC Documents Accompanying letter SPC 2 PDF /4/8/2/5/9/0800695284/docs/301110_1_supplprotectioncertificate20210621123202436.pdf
21/06/2021 Application Form First filed application form 4 PDF /4/8/2/5/9/0800695284/docs/301110_2_applicationform20210621123011197.pdf
21/06/2021 SPC Documents Summary of the characteristics of the product 9 PDF /4/8/2/5/9/0800695284/docs/301110_3_supplprotectioncertificate20210621123453921.pdf
21/06/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /4/8/2/5/9/0800695284/docs/301110_6_418373l174.pdf
21/06/2021 SPC Documents Marketing Authorization SPC 3 PDF /4/8/2/5/9/0800695284/docs/301110_7_supplprotectioncertificate20210621123313367.pdf